Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Madhava Rao Mannam, Srimurugan S.Pramod Kumar, Naga Raju Chamarthi & Prasad K. R. S.. (2020) Synthesis of novel 3-[(2R*)-2-[(2S*)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]-2-hydroxyethyl]-urea/thiourea derivatives and evaluation of their antimicrobial activities. Phosphorus, Sulfur, and Silicon and the Related Elements 195:1, pages 65-74.
Read now
Read now
Imran Ali, Mohd Suhail, Mohammad Nadeem Lone, Zeid A. Alothman & Abdulrahman Alwarthan. (2016) Chiral resolution of multichiral center racemates by different modalities of chromatography. Journal of Liquid Chromatography & Related Technologies 39:9, pages 435-444.
Read now
Read now
Donatella Del Sindaco, Maria Denitza Tinti, Luca Monzo & Giovanni Pulignano. (2010) Clinical and economic aspects of the use of nebivolol in the treatment of elderly patients with heart failure. Clinical Interventions in Aging 5, pages 381-393.
Read now
Read now
Erik Lipšic & Dirk J van Veldhuisen. (2010) Nebivolol in chronic heart failure: current evidence and future perspectives. Expert Opinion on Pharmacotherapy 11:6, pages 983-992.
Read now
Read now
Articles from other publishers (25)
Andrea Martinez, Mohit Lakkimsetti, Sameep Maharjan, Muhammad Ammar Aslam, Anouksha Basnyat, Shashwat Kafley, Subrahmanya saketh Reddy, Saima S Ahmed, Waleed Razzaq, Susmitha Adusumilli & Uzzam Ahmed Khawaja. (2023) Beta-Blockers and Their Current Role in Maternal and Neonatal Health: A Narrative Review of the Literature. Cureus.
Crossref
Crossref
Junyou Zhang & Ming-Hua Xu. (2023) The advance in transition metal-catalyzed asymmetric O–H, S–H insertion reactions. SCIENTIA SINICA Chimica 53:3, pages 447-463.
Crossref
Crossref
Katerina Baou, Vasiliki Katsi, Thomas Makris & Dimitris Tousoulis. (2021) Beta Blockers and Chronic Obstructive Pulmonary Disease (COPD): Sum of Evidence. Current Hypertension Reviews 17:3, pages 196-206.
Crossref
Crossref
Imran Ali, Mohd. Suhail, Hassan Y. Aboul-Enein & Tatiana Kon’kova. (2021) Recent Trends in Chiral Separations by 2D-HPLC. Chromatographia 84:6, pages 535-548.
Crossref
Crossref
Arruje Hameed, Tahir Farooq & Sadia Shabbir. 2021. Endocrine Disrupting Chemicals-induced Metabolic Disorders and Treatment Strategies. Endocrine Disrupting Chemicals-induced Metabolic Disorders and Treatment Strategies
357
365
.
Imran Ali, Mohd. Suhail & Hassan Y. Aboul-Enein. (2019) Advances in chiral multidimensional liquid chromatography. TrAC Trends in Analytical Chemistry 120, pages 115634.
Crossref
Crossref
Anamika KhaskelPranjit BarmanSubir Kumar MaitiUtpal Jana. (2018) Nebivolol nanoparticles: a first catalytic use in Biginelli and Biginelli-like reactions. Canadian Journal of Chemistry 96:12, pages 1021-1025.
Crossref
Crossref
Zhen TanZhichao Xiao, Jinhong Wei, Jingqun ZhangQiang ZhouChris D. Smith, Alma NaniGuogen WuLong-Sheng SongThomas G. Back, Michael FillS. R. Wayne Chen. (2016) Nebivolol suppresses cardiac ryanodine receptor-mediated spontaneous Ca2+ release and catecholaminergic polymorphic ventricular tachycardia. Biochemical Journal 473:22, pages 4159-4172.
Crossref
Crossref
Peter Cseplo, Zoltan Vamos, Ivan Ivic, Orsolya Torok, Attila Toth & Akos Koller. (2016) The Beta-1-Receptor Blocker Nebivolol Elicits Dilation of Cerebral Arteries by Reducing Smooth Muscle [Ca2+]i. PLOS ONE 11:10, pages e0164010.
Crossref
Crossref
Kyle J. DiehlBrian L. StaufferCaitlin A. DowTyler D. BammertDanielle L. BrunjesJared J. GreinerChristopher A. DeSouza. (2016) Chronic Nebivolol Treatment Suppresses Endothelin-1–Mediated Vasoconstrictor Tone in Adults With Elevated Blood Pressure. Hypertension 67:6, pages 1196-1204.
Crossref
Crossref
Imran Ali, Mohd. Suhail, Zeid A. AL‐Othman, Abdulrahman Alwarthan & Hassan Y. Aboul‐Enein. (2016) Enantiomeric resolution of multiple chiral centres racemates by capillary electrophoresis. Biomedical Chromatography 30:5, pages 683-694.
Crossref
Crossref
Norbert Handler, Andrea Wolkerstorfer & Helmut Buschmann. 2016. Lead Generation. Lead Generation
221
258
.
Dong Woon Kim, Md. Maqusood Alam, Young Hun Lee, M. Naseer A. Khan, Yong Zhang & Yong Sup Lee. (2015) An efficient and practical enantiospecific synthesis of methyl chromanone- and chroman-2-carboxylates. Tetrahedron: Asymmetry 26:17, pages 912-917.
Crossref
Crossref
Harika Ryakala, S. Dineshmohan, Alluri Ramesh & V. R. M. Gupta. (2015)
Formulation and
In Vitro
Evaluation of Bilayer Tablets of Nebivolol Hydrochloride and Nateglinide for the Treatment of Diabetes and Hypertension
. Journal of Drug Delivery 2015, pages 1-14.
Crossref
Crossref
Forugh Sanaee, Daniel Valente Neves, Vera Lucia Lanchote & Fakhreddin Jamali. (2013) Pharmacokinetics of nebivolol in the rat: low oral absorption, loss in the gut and systemic stereoselectivity. Biopharmaceutics & Drug Disposition 34:6, pages 312-320.
Crossref
Crossref
S. V Nedogoda, A. S Salasyuk, I. N Barykina, A. A Ledyaeva, V. V Tsoma & E. V Chumachek. (2013) Comparative analysis of the efficiency of the selective b-blocker nebivolol and the angiotensin II receptor blocker valsartan in men with hypertension, metabolic syndrome, and erectile dysfunction. CardioSomatics 4:2, pages 57-66.
Crossref
Crossref
Xiao‐Guang Song, Shou‐Fei Zhu, Xiu‐Lan Xie & Qi‐Lin Zhou. (2013) Enantioselective Copper‐Catalyzed Intramolecular Phenolic OH Bond Insertion: Synthesis of Chiral 2‐Carboxy Dihydrobenzofurans, Dihydrobenzopyrans, and Tetrahydrobenzooxepines. Angewandte Chemie International Edition 52:9, pages 2555-2558.
Crossref
Crossref
Xiao‐Guang Song, Shou‐Fei Zhu, Xiu‐Lan Xie & Qi‐Lin Zhou. (2013) Enantioselective Copper‐Catalyzed Intramolecular Phenolic OH Bond Insertion: Synthesis of Chiral 2‐Carboxy Dihydrobenzofurans, Dihydrobenzopyrans, and Tetrahydrobenzooxepines. Angewandte Chemie 125:9, pages 2615-2618.
Crossref
Crossref
Rudolf A. de Boer, Wolfram Doehner, Iwan C.C. van der Horst, Stefan D. Anker, Daphne Babalis, Michael Roughton, Andrew J. Coats, Marcus D. Flather & Dirk J. van Veldhuisen. (2010) Influence of Diabetes Mellitus and Hyperglycemia on Prognosis in Patients ≥70 Years Old With Heart Failure and Effects of Nebivolol (Data from the Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure [SENIORS]). The American Journal of Cardiology 106:1, pages 78-86.e1.
Crossref
Crossref
Debra W. KempJamie N. BrownToyin S. Tofade. (2009) Recent Advances in Pharmacotherapy. Journal of Pharmacy Practice 22:5, pages 446-466.
Crossref
Crossref
Maurizio Galderisi, Arcangelo D'Errico, Milena Sidiropulos, Pasquale Innelli, Oreste de Divitiis & Giovanni de Simone. (2009) Nebivolol induces parallel improvement of left ventricular filling pressure and coronary flow reserve in uncomplicated arterial hypertension. Journal of Hypertension 27:10, pages 2108-2115.
Crossref
Crossref
Roberto Dal Negro. (2009) Pulmonary effects of nebivolol. Therapeutic Advances in Cardiovascular Disease 3:4, pages 329-334.
Crossref
Crossref
Dirk J. van Veldhuisen, Alain Cohen-Solal, Michael Böhm, Stefan D. Anker, Daphne Babalis, Michael Roughton, Andrew J.S. Coats, Philip A. Poole-Wilson & Marcus D. Flather. (2009) Beta-Blockade With Nebivolol in Elderly Heart Failure Patients With Impaired and Preserved Left Ventricular Ejection Fraction. Journal of the American College of Cardiology 53:23, pages 2150-2158.
Crossref
Crossref
Turgay Celik, Atila Iyisoy, Ejder Kardesoglu & Francesco Fici. (2009) The anti-inflammatory effects of nebivolol in human coronary smooth muscle cells: Clinical implications. International Journal of Cardiology 133:3, pages 415-416.
Crossref
Crossref
Filomena de Nigris, Monica Rienzo, Concetta Schiano, Carmela Fiorito, Amelia Casamassimi & Claudio Napoli. (2008) Prominent cardioprotective effects of third generation beta blocker nebivolol against anthracycline-induced cardiotoxicity using the model of isolated perfused rat heart. European Journal of Cancer 44:3, pages 334-340.
Crossref
Crossref